Removal of hemangiosarcoma cells from canine blood with a cell salvage system and leukocyte reduction filter

Veterinary Surgery

Volumn 47, Issue 2, 2018, Pages 293-301

  Ciepluch, Brittany ^a   Wilson Robles, Heather ^a   Levine, Gwendolyn ^a   Smith, Roger ^a   Wright, Gus A ^a   Miller, Tasha ^a   O'Brien, Maureen T ^a   Thieman Mankin, Kelley M ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSARCOMA; ANIMAL; BLOOD; BLOOD SALVAGE; DISEASE MODEL; DOG; EVALUATION STUDY; FILTRATION; LEUKAPHERESIS; PATHOLOGY; PROCEDURES; VETERINARY;

ANIMALS; DISEASE MODELS, ANIMAL; DOGS; FILTRATION; HEMANGIOSARCOMA; LEUKOCYTE REDUCTION PROCEDURES; OPERATIVE BLOOD SALVAGE;

EID: 85038076557     PISSN: 01613499     EISSN: 1532950X     Source Type: Journal    
DOI: 10.1111/vsu.12760     Document Type: Article

References (61)

1. Pintar J, Breitschwert E, Hadre E, Spaulding K. Acute nontraumatic hemoabdomen in the dog: a retrospective analysis of 39 cases (1987-2001). J Am Anim Hosp Assoc. 2003;39:518-522.
2. Prittie J. Controversies related to red blood cell transfusion in critically ill patients. J Vet Emerg Crit Care (San Antonio). 2010;20:167-176.
3. Kerl ME, Höhenhaus AE. Packed red blood cell transfusions in dogs: 131 cases (1989). J Am Vet Med Assoc. 1993;202:1495-1499.
4. Amato A, Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev. 2006;1:CD005033.
5. Holowaychuk M, Leader J, Monteith G. Risk factors for transfusion-associated complications and nonsurvival in dogs receiving packed red blood cell transfusions: 211 cases (2008-2011). J Am Vet Med Assoc. 2014;244:431-437.
6. Cata J, Wang H, Gottumukkala V, Reuben J, Kessler D. Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. Br J Anaesth 2013;110:690-701.
7. Napolitano LM, Corwin HL. Efficacy of red blood cell transfusion in the critically ill. Crit Care Clin. 2004;20:255-268.
8. Corwin HLM, Gettinger AM, Pearl RGM. The CRIT study: anemia and blood transfusion in the critically ill—current clinical practice in the United States. Crit Care Med. 2004;3:39-52.
9. Vincent J, Baron J, Reinhart K, Gattinoni L. Anemia and blood transfusion in critically ill patients. J Am Med Assoc. 2002;288:1499-1507.
10. Hirano T, Yamanaka J, Iimuro Y, Fujimoto J. Long-term safety of autotransfusion during hepatectomy for hepatocellular carcinoma. Surg Today. 2005;35:1042-1046.
11. Highmore W. Overlooked source of blood supply for transfusion in post-partum haemorrhage. The Lancet. 1874;17:89.
12. Bower MR, Ellis SF, Scoggins CR, McMasters KM. Phase II comparison study of intraoperative autotransfusion for major oncologic procedures. Ann Surg Oncol. 2011;18: 166-173.
13. Ashworth A, Klein AA. Cell salvage as part of a blood conservation strategy in anaesthesia. Br J Anaesth. 2010;105:401-416.
14. Hirst C, Adamantos S. Autologous blood transfusion following red blood cell salvage for the management of blood loss in 3 dogs with hemoperitoneum. J Vet Emerg Crit Care (San Antonio). 2012;22:355-360.
15. Kellett-Gregory LM, Seth M, Adamantos S. Autologous canine red blood cell transfusion using cell salvage devices. J Vet Emerg Crit Care (San Antonio). 2013;23:82-86.
16. Waters J. Indications and contraindications of cell salvage. Transfusion. 2004;44:40S-44S.
17. Trudeau JD, Waters T, Chipperfield K. Should intraoperative cell-salvaged blood be used in patients with suspected or known malignancy? Can J Anesth. 2012;59:1058-1070.
18. Kumar N, Chen Y, Zaw AS. Use of intraoperative cell-salvage for autologous blood transfusions in metastatic spine tumour surgery: a systematic review. Lancet Oncol. 2014;15:33-41.
19. Day TK. Shock. Pathophysiology, diagnosis, and treatment. In: Slatter DH, ed. Textbook of Small Animal Surgery. 3rd ed. Philadelphia, PA: Saunders; 2003:1-17.
20. Homann B, Zenner HP, Schauber J. Tumor cells carried through autotransfusion. Are these cells still malignant? Acta Anaesthesiol Belg. 1984;35:51-59.
21. Stoffel JT, Topjian L, Libertino JA. Analysis of peripheral blood for prostate cells after autologous transfusion given during radical prostatectomy. BJU Int. 2005;96:313-315.
22. Kongsgaard UE, Wang MY, Kvalheim G. Leukocyte depletion filter removes cancer cells in human blood. Acta Anaesth Scand. 1996;40:118-120.
23. Futamura N, Nakanishi H, Hirose H. The effects of storage on the survival of cancer cells in blood and efficient elimination of contaminating cancer cells by a leukocyte depletion filter. Am Surgeon. 2005;71:585-590.
24. Miller GV, Ramsden CW, Primrose JN. Autologous transfusion: an alternative to transfusion with banked blood during surgery for cancer. Br J Surg. 1991;78:713-715.
25. Fruhauf N. Filtration of malignant cells: tumour cell depletion in an ex vivo model using a leukocyte adhesion filter. Perfusion. 2001;16:51-55.
26. Catling S, Williams S, Freites O, Rees M. Use of a leucocyte filter to remove tumour cells from intra-operative cell salvage blood. Anaesthesia. 2008;63(12):1332-1338.
27. Martin RCG, Wellhausen SR, Moehle DA. Evaluation of intraoperative autotransfusion filtration for hepatectomy and pancreatectomy. Ann Surg Oncol. 2005;12:1017-1024.
28. Thamm DH, Dickerson EB, Achtar N, Lewis R. Biological and molecular characterization of a canine hemangiosarcoma-derived cell line. Res Vet Sci. 2006;81:76-86.
29. Lamerato Kozicki A, Lamerato Kozicki K, Helm C, Jubala G. Canine hemangiosarcoma originates from hematopoietic precursors with potential for endothelial differentiation. Exp Hematol. 2006;34:870-878.
30. Lamb J, Thieman Mankin K, Levine G, Thompson J. Electrolyte and acid/base changes in dogs undergoing autologous blood transfusion via a cell salvage device. Can Vet J. 2015;56:947-952.
31. McDevitt RI, Ruaux CG, Baltzer. Influence of transfusion technique on survival of autologous red blood cells in the dog. J Vet Emerg Crit Care (San Antonio). 2011;21:209-216.
32. Foamier SP, Dickerson EB, Scott AM, Bianco SR. Canine malignant hemangiosarcoma as a model of primitive angiogenic endothelium. Lab Invest. 2004;84:562-567.
33. Gwak MS, Lee KW, Kim SY. Can a leukocyte depletion filter (LDF) reduce the risk of reintroduction of hepatocellular carcinoma cells? Liver Transplation. 2005;11:331-335.
34. Torre GC, Ferrari M, Favre A. A new technique for intraoperative blood recovery in the cancer patient. Eur J Surg Oncol. 1994;20:565-570.
35. Silverstein D, Campbell J. Fluid therapy. In: Tobias KM, Johnston SA, eds. Veterinary Surgery: Small Animal. 1st ed. St. Louis, MO: Elsevier; 2011:43-83.
36. Liang TB, Li DL, Liang L. Intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma: efficiency of leukocyte depletion filters in the removal of tumor cells. Transplant. 2008;85:863-869.
37. Tartter P. The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg. 1992;216:633-638.
38. Hyung WJ, Noh SH, Shin DW, Huh JHJ. Adverse effects of perioperative transfusion on patients with stage III and IV gastric cancer. Ann Surg Oncol. 2002;9:5-12.
39. Rosenberg SA, Seipp CA, White DE, Wesley R. Perioperative blood transfusions are associated with increased rates of recurrence and decreased survival in patients with high-grade soft-tissue sarcomas of the extremities. J Clin Oncol. 1985;3:698-709.
40. Takemura M. Effect of substituting allogenic blood transfusion with autologous blood transfusion on outcomes after radical oesophagectomy for cancer. Ann Thorac Cardiovasc Surg. 2005;11:293-300.
41. Fujimoto J, Okamoto E, Yamanaka N, Oriyama T. Efficacy of autotransfusion in hepatectomy for hepatocellular carcinoma. Arch Surg. 1993;128:1065-1069.
42. Akbulut S, Kayaalp C, Yilmaz M, Ince V. Effect of autotransfusion system on tumor recurrence and survival in hepatocellular carcinoma patients. World J Gastroenterol. 2013;19:1625-1631.
43. Horimi T, Kagawa S, Ninomiya M, Yoshida E. Possible induction by blood transfusion of immunological tolerance against growth of transplanted tumors in mice. Acta Med Okayama. 1983;37:259-263.
44. Nielsen HJ. Time-dependent, spontaneous release of white cell- and platelet-derived bioactive substances from stored human blood. Transfusion. 1996;36:960-965.
45. McMichael MA, Smith SA, Galligan KS. Effect of leukoreduction on transfusion-induced inflammation in dogs. J Vet Internal Med. 2010;24:1131-1137.
46. Graf C, Raila J, Schweigert F, Kohn B. Effect of leukoreduction treatment on vascular endothelial growth factor concentration in stored canine blood transfusion products. Am J Vet Res. 2012;73:2001-2006.
47. Clifford CA. Plasma vascular endothelial growth factor concentrations in healthy dogs and dogs with hemangiosarcoma. J Vet Internal Med. 2001;15:131-135.
48. Corsi R, McMichael M, Smith S, O'Brien M. Cytokine concentration in stored canine erythrocyte concentrates. J Vet Emerg Crit Care (San Antonio). 2014;24:259-263.
49. Herring J, Smith S, McMichael M, O'Brien M. Microparticles in stored canine RBC concentrates. Vet Clin Pathol. 2013;42:163-169.
50. Herring J, McMichael M, Smith S. Microparticles in health and disease. J Vet Intern Med. 2013;27:1020-1033.
51. Kim JH, Frantz AM, Anderson KL, Graef AJ. Interleukin-8 promotes canine hemangiosarcoma growth by regulating the tumor microenvironment. Exp Cell Res. 2014;323:155-164.
52. Greening DW, Gopal SK, Mathias RA, Liu L. Emerging roles of exosomes during epithelial-mesenchymal transition and cancer progression. Semin Cell Dev Biol. 2015;40:60-71.
53. Oefelein MG, Kaul K, Herz B, Blum MD. Molecular detection of prostate epithelial cells from the surgical field and peripheral circulation during radical prostatectomy. J Urol. 1996;155:238-242.
54. Kudo H, Fujita H, Hanada Y, Hayami H. Cytological and bacteriological studies of intraoperative autologous blood in neurosurgery. Surg Neurol. 2004;62:195-199.
55. Yamaguchi K, Takagi Y, Aoki S, Futamura M. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg. 2000;232:58-65.
56. Hansen E, Wolff N, Knuechel R. Tumor cells in blood shed from the surgical field. Arch Surg. 1995;130:387-393.
57. Weiss L. Metastatic inefficiency. Adv Cancer Res. 1990;54:159-211.
58. Weina Wang, Kisker DW, Thamm DH, Hua Shao. Optofluidic intracavity spectroscopy of canine hemangiosarcoma. IEEE Trans Biomed Eng. 2011;58:853-860.
59. Higgs VA, Rudloff E, Kirby R, Linklater AKJ. Autologous blood transfusion in dogs with thoracic or abdominal hemorrhage: 25 cases (2007-2012). J Vet Emerg Crit Care (San Antonio). 2015;25:731-738.
60. Brownlee L. Use of a prestorage leukoreduction filter effectively removes leukocytes from canine whole blood while preserving red blood cell viability. J Vet Internal Med. 2000;14:412-417.
61. Ray JM. Erythrocyte survival following intraoperative autotransfusion in spinal surgery: an in vivo comparative study and 5-year update. Spine. 1986;11:879-882.